TD Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $538K | Buy |
+9,400
| New | +$515K | ﹤0.01% | 1171 |
|
|
2025
Q4 | – | Sell |
-16,605
| Closed | -$899K | – | 1245 |
|
|
2025
Q3 | $899K | Sell |
16,605
-636
| -4% | -$36.4K | ﹤0.01% | 1108 |
|
|
2025
Q2 | $948K | Sell |
17,241
-17,881
| -51% | -$1.05M | ﹤0.01% | 1069 |
|
|
2025
Q1 | $2.48M | Sell |
35,122
-59,008
| -63% | -$3.97M | ﹤0.01% | 910 |
|
|
2024
Q4 | $6.19M | Sell |
94,130
-9,125
| -9% | -$611K | 0.01% | 754 |
|
|
2024
Q3 | $7.29M | Sell |
103,255
-40,642
| -28% | -$3.4M | 0.01% | 703 |
|
|
2024
Q2 | $11.8M | Sell |
143,897
-14,724
| -9% | -$1.23M | 0.01% | 597 |
|
|
2024
Q1 | $13.9M | Sell |
158,621
-32,409
| -17% | -$2.9M | 0.01% | 566 |
|
|
2023
Q4 | $18.4M | Buy |
191,030
+17,858
| +10% | +$1.58M | 0.02% | 496 |
|
|
2023
Q3 | $15.3M | Buy |
173,172
+72,742
| +72% | +$6.47M | 0.02% | 494 |
|
|
2023
Q2 | $8.71M | Sell |
100,430
-2,839
| -3% | -$267K | 0.01% | 628 |
|
|
2023
Q1 | $10M | Buy |
103,269
+23,768
| +30% | +$2.46M | 0.01% | 605 |
|
|
2022
Q4 | $8.23M | Buy |
79,501
+24,485
| +45% | +$2.3M | 0.01% | 636 |
|
|
2022
Q3 | $4.68M | Buy |
55,016
+5,551
| +11% | +$494K | 0.01% | 774 |
|
|
2022
Q2 | $4.1M | Sell |
49,465
-6,158
| -11% | -$490K | ﹤0.01% | 815 |
|
|
2022
Q1 | $4.29M | Buy |
55,623
+27,485
| +98% | +$2.3M | ﹤0.01% | 860 |
|
|
2021
Q4 | $2.49M | Sell |
28,138
-1,007
| -3% | -$83.1K | ﹤0.01% | 1081 |
|
|
2021
Q3 | $2.25M | Buy |
29,145
+56
| +0.2% | +$4.42K | ﹤0.01% | 1052 |
|
|
2021
Q2 | $2.23M | Sell |
29,089
-35,000
| -55% | -$2.77M | ﹤0.01% | 1065 |
|
|
2021
Q1 | $4.84M | Sell |
64,089
-369
| -0.6% | -$30.1K | 0.01% | 837 |
|
|
2020
Q4 | $5.65M | Buy |
64,458
+403
| +0.6% | +$32K | 0.01% | 757 |
|
|
2020
Q3 | $4.87M | Sell |
64,055
-7,111
| -10% | -$719K | 0.01% | 712 |
|
|
2020
Q2 | $8.78M | Buy |
71,166
+2,472
| +4% | +$246K | 0.01% | 541 |
|
|
2020
Q1 | $5.8M | Sell |
68,694
-19,200
| -22% | -$1.65M | 0.01% | 591 |
|
|
2019
Q4 | $7.43M | Buy |
87,894
+3,316
| +4% | +$250K | 0.01% | 630 |
|
|
2019
Q3 | $5.7M | Buy |
84,578
+5,300
| +7% | +$408K | 0.01% | 654 |
|
|
2019
Q2 | $6.79M | Sell |
79,278
-10,333
| -12% | -$884K | 0.01% | 618 |
|
|
2019
Q1 | $7.96M | Buy |
89,611
+8,051
| +10% | +$746K | 0.01% | 574 |
|
|
2018
Q4 | $6.95M | Sell |
81,560
-6,886
| -8% | -$655K | 0.01% | 569 |
|
|
2018
Q3 | $8.58M | Buy |
88,446
+540
| +0.6% | +$53.9K | 0.01% | 578 |
|
|
2018
Q2 | $8.28M | Buy |
87,906
+14,107
| +19% | +$1.24M | 0.01% | 566 |
|
|
2018
Q1 | $5.98M | Sell |
73,799
-4,222
| -5% | -$362K | 0.01% | 635 |
|
|
2017
Q4 | $6.96M | Buy |
78,021
+3,397
| +5% | +$295K | 0.01% | 607 |
|
|
2017
Q3 | $6.95M | Buy |
74,624
+11,465
| +18% | +$1.01M | 0.01% | 591 |
|
|
2017
Q2 | $5.74M | Buy |
63,159
+127
| +0.2% | +$11.6K | 0.01% | 652 |
|
|
2017
Q1 | $5.53M | Buy |
63,032
+13,365
| +27% | +$1.19M | 0.01% | 661 |
|
|
2016
Q4 | $4.11M | Buy |
49,667
+402
| +0.8% | +$34.6K | 0.01% | 722 |
|
|
2016
Q3 | $4.56M | Buy |
49,265
+342
| +0.7% | +$32.2K | 0.01% | 723 |
|
|
2016
Q2 | $3.81M | Sell |
48,923
-42,662
| -47% | -$3.63M | 0.01% | 749 |
|
|
2016
Q1 | $7.55M | Sell |
91,585
-13,798
| -13% | -$1.12M | 0.01% | 557 |
|
|
2015
Q4 | $11M | Buy |
105,383
+310
| +0.3% | +$32.4K | 0.02% | 464 |
|
|
2015
Q3 | $11.1M | Buy |
105,073
+6,656
| +7% | +$889K | 0.02% | 436 |
|
|
2015
Q2 | $13.5M | Sell |
98,417
-3,600
| -4% | -$446K | 0.02% | 439 |
|
|
2015
Q1 | $12.7M | Buy |
102,017
+44,016
| +76% | +$4.66M | 0.02% | 437 |
|
|
2014
Q4 | $5.24M | Buy |
58,001
+1,601
| +3% | +$133K | 0.01% | 650 |
|
|
2014
Q3 | $4.07M | Sell |
56,400
-1,800
| -3% | -$118K | 0.01% | 691 |
|
|
2014
Q2 | $3.62M | Sell |
58,200
-2,800
| -5% | -$169K | 0.01% | 733 |
|
|
2014
Q1 | $4.16M | Sell |
61,000
-5,000
| -8% | -$368K | 0.01% | 692 |
|
|
2013
Q4 | $4.64M | Sell |
66,000
-600
| -0.9% | -$40.7K | 0.01% | 646 |
|
|
2013
Q3 | $4.81M | Sell |
66,600
-4,300
| -6% | -$286K | 0.01% | 612 |
|
|
2013
Q2 | $3.96M | Buy |
+70,900
| New | +$4.42M | 0.01% | 639 |
|
Other funds holding BMRN
VCM
VPM
TD Asset Management's BMRN Position: Q2 2026 in Review
TD Asset Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 9,400 shares worth $538K. The stake represents ﹤0.01% of the portfolio and ranks #1171 among its holdings. This is a return to the name: TD Asset Management previously reported a position in BMRN as recently as Q3 2025.
TD Asset Management first reported a position in BMRN in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.4M in Q4 2023. 413 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- TD Asset Management held 9,400 shares of BioMarin Pharmaceuticals worth $538K as of Q2 2026.
- BioMarin Pharmaceuticals was a new TD Asset Management position in Q2 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1171 holding.
- TD Asset Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- TD Asset Management's BioMarin Pharmaceuticals position peaked at $18.4M in Q4 2023.
- 413 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.